Multiple Myeloma Cells Express Key Immunoregulatory Cytokines and Modulate the Monocyte Migratory Response.

about

Multiple Myeloma Cells Express Key Immunoregulatory Cytokines and Modulate the Monocyte Migratory Response.

Item

http://www.wikidata.org/entity/Q38697483

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Multiple Myeloma Cells Express ...... e Monocyte Migratory Response.

@en

type

Item

label

Multiple Myeloma Cells Express ...... e Monocyte Migratory Response.

@en

prefLabel

Multiple Myeloma Cells Express ...... e Monocyte Migratory Response.

@en

P1476

Multiple Myeloma Cells Express ...... he Monocyte Migratory Response

@en

P2093

Alexandre Morrot

http://www.w3.org/2001/XMLSchema#string

Ana Flávia Fernandes Ribas Nardy

http://www.w3.org/2001/XMLSchema#string

Angelo Maiolino

http://www.w3.org/2001/XMLSchema#string

Juliana Echevarria Lima

http://www.w3.org/2001/XMLSchema#string

Jéssica Santos Lemos

http://www.w3.org/2001/XMLSchema#string

Leonardo Freire-de-Lima

http://www.w3.org/2001/XMLSchema#string

Leonardo Marques da Fonseca

http://www.w3.org/2001/XMLSchema#string

Luciana Conde

http://www.w3.org/2001/XMLSchema#string

P2860

Multiple myeloma: 2014 Update on diagnosis, risk-stratification, and management

Coordinated regulation of myeloid cells by tumours

Taking dendritic cells into medicine

In vivo analysis of dendritic cell development and homeostasis

Myeloma plasma cells alter the bone marrow microenvironment by stimulating the proliferation of mesenchymal stromal cells.

Hypoxia-inducible factor-2 is a novel regulator of aberrant CXCL12 expression in multiple myeloma plasma cells.

Malignant hematopoietic cell lines: in vitro models for the study of multiple myeloma and plasma cell leukemia.

Characterization of the Toll-like receptor expression profile in human multiple myeloma cells.

Dendritic cells accumulate in the bone marrow of myeloma patients where they protect tumor plasma cells from CD8+ T-cell killing.

BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FMED.2017.00092

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Erivan S Ramos-Junior

P577

2017-06-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28702457

http://www.w3.org/2001/XMLSchema#string

P932

5484767

http://www.w3.org/2001/XMLSchema#string